Repligen Corp. (RGEN)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 4.37
   
  • Change Today:
    $-0.16
  • 52 Week High: $7.26
  • 52 Week Low: $2.64
  • Currency: US Dollars
  • Shares Issued: 30.85m
  • Volume: 136,315
  • Market Cap: $134.80m
  • RiskGrade: 568
  • Beta: 0.20

Latest ShareCast News

Repligen Corp. ShareCast News

No recent information was found.

Repligen Corp. Newspaper Links

Repligen and M.I.T. Sue ImClone Over Cancer Drug 06-May-2004 New York Times
Trials End Parents' Hopes for Autism Drug 06-Jan-2004 New York Times

Repligen Corp. Tips & Analysis

Market movers 11-Sep-2007 Chicago Tribune

Repligen Corp. News Wires

Stock Market Alert! Mar. 10, 2004, Part 2 10-Mar-2004 Market Wire

Other Repligen Corp. News

Repligen Receives Second Research Grant from the... 15-Dec-2009 PR Newswire
Repligen Reports Phase 3 Clinical Trial Results ... 09-Dec-2009 PR Newswire
Repligen Announces Conference Call to Discuss Ph... 08-Dec-2009 PR Newswire
Repligen Reports Second Quarter Fiscal Year 2010... 05-Nov-2009 PR Newswire
Repligen to Present at the Merriman Curhan Ford ... 03-Nov-2009 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Repligen Corp. Market Data

Currency US Dollars
Share Price $ 4.37
Change Today $ -0.16
% Change -3.53 %
52 Week High $7.26
52 Week Low $2.64
Volume 136,315
Shares Issued 30.85m
Market Cap $134.80m
Beta 0.20
RiskGrade 568

Trades for 25-May-2012

Time Volume / Share Price
16:00 228 @ $4.37
15:59 100 @ $4.37
15:59 202 @ $4.37
15:59 100 @ $4.37
15:59 143 @ $4.37

Top of Page